AADvac1 for alzheimer disease

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 11 Sep 2025: Trial registered, NCT07167966

The trials

NCT07167966: Alzheimer's Tau Platform: Regimen A - AADvac1

State
Under way
Phase
Phase 2
People
450 planned
Started
3 Nov 2026
Primary completion
31 Aug 2028
Arms
AADvac1 monotherapy, Combination AADvac1 therapy with donanemab
Results
None posted
  1. 11 Sep 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.